Screener / SEC EDGAR /CIK 0001722482 /10-K filed Feb 11, 2026, compared with Feb 7, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Technology · Lab Instruments

Avantor, Inc. AVTR

Compare with peers Embed
Earnings releases

Latest results release: Oct 28, 2026

8-K item 2.02, exhibit 99

What AVTR's management wrote with each quarter's results: the press release and, when the company files them, its prepared remarks or the call transcript. The call itself is not filed with SEC, so most quarters have the release only.

Adjusted vs GAAP earnings per share

In the company's own words · read from each release, never computed

In its release of Oct 28, 2026, AVTR reported $0.30 per share under GAAP and $0.22 on its own adjusted basis: the adjusted number is -27% below GAAP.

GAAP EPS $0.15, release Feb 14, 2024: Diluted GAAP EPS of $0.15 Adjusted EPS $0.25, release Feb 14, 2024: Diluted GAAP EPS of $0.15; adjusted EPS of $0.25 +67% 2024-02 GAAP EPS $0.09, release Apr 26, 2024: Diluted GAAP EPS of $0.09 Adjusted EPS $0.22, release Apr 26, 2024: Diluted GAAP EPS of $0.09; adjusted EPS of $0.22 +144% 2024-04 GAAP EPS $0.14, release Jul 26, 2024: Diluted GAAP EPS of $0.14 Adjusted EPS $0.25, release Jul 26, 2024: Diluted GAAP EPS of $0.14; adjusted EPS of $0.25 +79% 2024-07 GAAP EPS $0.08, release Oct 25, 2024: Diluted GAAP EPS of $0.08 Adjusted EPS $0.26, release Oct 25, 2024: Diluted GAAP EPS of $0.08; adjusted EPS of $0.26 +225% 2024-10 GAAP EPS $0.73, release Feb 7, 2025: Diluted GAAP EPS of $0.73 Adjusted EPS $0.27, release Feb 7, 2025: Diluted GAAP EPS of $0.73; adjusted EPS of $0.27 -63% 2025-02 GAAP EPS $0.09, release Apr 25, 2025: Diluted GAAP EPS of $0.09 Adjusted EPS $0.23, release Apr 25, 2025: Diluted GAAP EPS of $0.09; adjusted EPS of $0.23 +156% 2025-04 GAAP EPS $0.09, release Aug 1, 2025: Diluted GAAP EPS of $0.09 Adjusted EPS $0.24, release Aug 1, 2025: Diluted GAAP EPS of $0.09; adjusted EPS of $0.24 +167% 2025-08 GAAP EPS $-1.04, release Oct 29, 2025: Net loss of $712 million and diluted GAAP loss per share of $1.04, including a non-cash goodwill impairment charge of $785 million Adjusted EPS $0.22, release Oct 29, 2025: Adjusted EBITDA of $268 million; adjusted EPS of $0.22 2025-10 GAAP EPS $0.08, release Feb 11, 2026: Diluted GAAP EPS of $0.08 Adjusted EPS $0.22, release Feb 11, 2026: Diluted GAAP EPS of $0.08; adjusted EPS of $0.22 +175% 2026-02 GAAP EPS $0.06, release Apr 29, 2026: Diluted GAAP EPS of $0.06 Adjusted EPS $0.17, release Apr 29, 2026: Diluted GAAP EPS of $0.06; adjusted EPS of $0.17 +183% 2026-04 GAAP EPS $0.06, release Jul 29, 2026: Diluted GAAP EPS of $0.06 Adjusted EPS $0.21, release Jul 29, 2026: Diluted GAAP EPS of $0.06; adjusted EPS of $0.21 +250% 2026-07 GAAP EPS $0.30, release Oct 28, 2026: Diluted GAAP EPS of $0.30 Adjusted EPS $0.22, release Oct 28, 2026: Diluted GAAP EPS of $0.30; adjusted EPS of $0.22 -27% 2026-10
GAAP EPSAdjusted EPS, as the company defines itThe figure on top is how far adjusted is from GAAP. Click a bar for the sentence.
The company's words, latest release
Diluted GAAP EPS of $0.30 release
Diluted GAAP EPS of $0.30; adjusted EPS of $0.22 release

Both numbers are read from the words of each release (usually the highlights), never computed by us; hover a number for its sentence. Quarters where the release gives them only in a table are not shown. The company decides what "adjusted" leaves out; the full reconciliation is in the release.

Read and search

Every release, in full · linked to sec.gov

Press release Oct 28, 2026 · EX-99.1

Avantor® Reports Third Quarter 2026 Results

Open on SEC

• Raised FY 2026 organic revenue growth, adjusted EPS and free cash flow guidance

–Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, reports results that exceeded management’s expectations for revenue and adjusted EPS for the third fiscal quarter of 2026.

Emmanuel Ligner, President and Chief Executive Officer, says: “We are delighted to return to year-over-year growth in the third quarter. We are not done with our Revival journey yet, but this achievement reflects the dedication of our associates and the progress we are making to sharpen our strategic focus and improve execution. Third quarter results exceeded our expectations across revenue and adjusted EPS, and we generated robust free cash flow that allowed us to further strengthen our balance sheet.

“VWR Distribution & Services delivered another quarter of improving revenue performance, with organic growth accelerating to 5.8%, and Bioscience & Medtech Products returned to organic growth as expected. We believe that improving execution and stronger end markets provide a foundation for sustained revenue growth, and we remain focused on execution to build on our positive momentum,” Ligner concludes.

For the three months ended September 30, 2026, net sales were $1,698.3 million, which was up 4.6% compared to the third quarter of 2025. Foreign currency translation had a negative impact of 0.6%, resulting in a 5.2% increase in net sales on an organic basis.

Net income increased to $203.4 million from a net loss of $711.8 million in the third quarter of 2025, and net income margin was 12.0%; adjusted net income was $146.4 million compared to $151.1 million in the prior-year period. Adjusted EBITDA was $256.9 million, with an adjusted EBITDA margin of 15.1%.

Operating income was $139.5 million, with an operating income margin of 8.2%; adjusted operating income was $227.6 million, with an adjusted operating income margin of 13.4%.

Diluted earnings per share on a GAAP basis was $0.30, and adjusted diluted earnings per share was $0.22.

• Net sales were $1,233.8 million, a reported increase of 5.0%, as compared to $1,175.0 million in the third quarter of 2025. Foreign currency translation had a negative impact of 0.8%, resulting in a sales increase of 5.8% on an organic basis.

• Adjusted Operating Income was $119.4 million as compared to $132.0 million in the comparable prior period. Adjusted Operating Income margin was 9.7%. Adjusted Operating Income margin declined versus the prior year due to unfavorable product mix and higher SG&A expenses, partially offset by higher sales volume.

• Net sales were $464.5 million, a reported increase of 3.5%, as compared to $448.8 million in the third quarter of 2025. Foreign currency translation had a negative impact of 0.1%, resulting in a 3.6% sales increase on an organic basis.

• Adjusted Operating Income was $123.4 million, as compared to $119.3 million in the comparable prior period. Adjusted Operating Income margin was 26.6%. Adjusted Operating Income margin was flat versus the prior year due to higher sales volume and commercial excellence, partially offset by higher SG&A expenses.

Adjusted Operating Income is Avantor's segment reporting profitability measure under generally accepted accounting principles and is used by management to measure and evaluate the performance of our Company’s business segments.

As of September 30, 2026, total debt, gross, was $3,699.7 million and cash and cash equivalents were $464.3 million.

GAAP net leverage was 9.6x, and adjusted net leverage was 3.1x, as of September 30, 2026.

For the three months ended September 30, 2026, operating cash flow was $195.1 million, while free cash flow was $156.2 million.

(1) Non-GAAP measure (definitions and/or reconciliations below). We are unable to provide a reconciliation of the non-GAAP measures provided in our full-year 2026 guidance without unreasonable effort because of the difficulty in forecasting and quantifying certain amounts and adjustment items with a reasonable degree of certainty including net income, restructuring charges, foreign currency exchange gains and losses and income tax expense. These amounts are dependent upon future events and may be outside of our control. We note that these items could have a significant impact on our full-year results determined in accordance with GAAP.

• Reported revenue growth range is +1.5% to +2.0%, reflecting +0.75% foreign exchange tailwind

• Net interest expense is expected to decline modestly when compared to Fiscal 2025

We will host a conference call to discuss our results today, October 28, 2026 at 8:00 a.m. Eastern Time. The live webcast and presentation, as well as a replay, will be available on the investor section of Avantor's website .

Avantor ® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visit corporate.avantorsciences.com and find us on LinkedIn , X (Twitter) and Facebook .

To evaluate our performance, we monitor a number of key indicators. As appropriate, we supplement our results of operations determined in accordance with U.S. generally accepted accounting principles (“GAAP”) with certain non- GAAP financial measures that we believe are useful to investors, creditors and others in assessing our performance. These measures should not be considered in isolation or as a substitute for reported GAAP results because they may include or exclude certain items as compared to similar GAAP-based measures, and such measures may not be comparable to similarly titled measures reported by other companies. Rather, these measures should be considered as an additional way of viewing aspects of our operations that provide a more complete understanding of our business. We strongly encourage investors to review our consolidated financial statements included in reports filed with the SEC in their entirety and not rely solely on any one single financial measure or communication.

The non-GAAP financial measures used in this press release are sales growth (decline) on an organic basis, Adjusted Operating Income, Adjusted Operating Income margin, Adjusted EBITDA, Adjusted EBITDA margin, adjusted net income, adjusted EPS, adjusted net leverage, free cash flow and free cash flow conversion.

• Organic net sales growth (decline) eliminates from our reported net sales change the impacts of revenues from acquisitions and divestitures that occurred in the last year (as applicable) and changes in foreign currency exchange rates. We believe that this measurement is useful to investors as a way to measure and evaluate our underlying commercial operating performance consistently across our segments and the periods presented. This measure is used by our management for the same reason.

• Adjusted Operating Income is our operating income or loss adjusted for the following items: (i) amortization of acquired intangible assets, (ii) charges associated with the impairment of certain assets, (iii) gain or loss on sale of business, and (iv) certain other adjustments. Adjusted Operating Income margin is Adjusted Operating Income divided by net sales as determined under GAAP. We believe that these measures are useful to investors as ways to analyze the underlying trends in our business consistently across the periods presented. These measures are used by our management for the same reason. Additionally, Adjusted Operating Income is our segment reporting profitability measure under GAAP.

• Adjusted EBITDA is our net income or loss adjusted for the following items: (i) interest expense, (ii) income tax expense, (iii) amortization of acquired intangible assets, (iv) depreciation expense, (v) losses on extinguishment of debt, (vi) charges associated with the impairment of certain assets, (vii) gain or loss on sale of business, and (viii) certain other adjustments. Adjusted EBITDA margin is Adjusted EBITDA divided by net sales as determined under GAAP. We believe that these measures are useful to investors as ways to analyze the underlying trends in our business consistently across the periods presented. These measures are used by our management for the same reason.

• Adjusted net income is our net income or loss first adjusted for the following items: (i) amortization of acquired intangible assets, (ii) losses on extinguishment of debt, (iii) charges associated with the impairment of certain assets, (iv) gain or loss on sale of business, and (v) certain other adjustments. From this amount, we then add or subtract an assumed incremental income tax impact on the above-noted pre-tax adjustments, using estimated tax rates, to arrive at Adjusted Net Income. We believe that this measure is useful to investors as a way to analyze the business consistently across the periods presented. This measure is used by our management for the same reason.

• Adjusted EPS is our adjusted net income divided by our diluted GAAP weighted average share count adjusted for anti-dilutive instruments. We believe that this measure is useful to investors as an additional way to analyze the underlying trends in our business consistently across the periods presented. This measure is used by our management for the same reason.

• Adjusted net leverage is equal to our gross debt, reduced by our cash and cash equivalents, divided by our trailing 12-month Adjusted EBITDA (excluding stock- based compensation expense and including the expected run-rate effect of cost synergies and the incremental results of completed acquisitions and divestitures as if those acquisitions and divestitures had occurred on the first day of the trailing 12-month period). We believe that this measure is useful to investors as a way to evaluate and measure the Company’s capital allocation strategies and the underlying trends in the business. This measure is used by our management for the same reason.

• Free cash flow is equal to our cash flows from operating activities, less capital expenditures, plus direct transaction costs and income taxes paid related to acquisitions and divestitures (as applicable) in the period. Free cash flow conversion is free cash flow divided by adjusted net income. We believe that these measures are useful to investors as they provide a view on the Company’s ability to generate cash for use in financing or investing activities. These measures are used by our management for the same reason.

Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are included in the tables accompanying this release.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and are subject to the safe harbor created thereby under the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this press release are forward-looking statements. Forward-looking statements discuss our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business. These statements may be preceded by, followed by or include the words “aim,” “anticipate,” “assumption,” “believe,” “continue,” “estimate,” “expect,” “forecast,” “goal,” “guidance,” “intend,” “likely,” “long-term,” “near-term,” “objective,” “opportunity,” “outlook,” “plan,” “potential,” “project,” “projection,” “prospects,” “seek,” “target,” “trend,” “can,” “could,” “may,” “should,” “would,” “will,” the negatives thereof and other words and terms of similar meaning.

Forward-looking statements are inherently subject to risks, uncertainties and assumptions; they are not guarantees of performance. You should not place undue reliance on these statements. We have based these forward-looking statements on our current expectations and projections about future events. Although we believe that our assumptions made in connection with the forward-looking statements are reasonable, we cannot assure you that the assumptions and expectations will prove to be correct. Factors that could contribute to these risks, uncertainties and assumptions include, but are not limited to, the factors described in “Risk Factors” in our most recent Annual Report on Form 10-K, and subsequent quarterly reports on Form 10-Q, as such risk factors may be updated from time to time in our periodic filings with the SEC.

All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the foregoing cautionary statements. In addition, all forward-looking statements speak only as of the date of this press release. We undertake no obligations to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise other than as required under the federal securities laws.

September 30, December 31, (in millions) 2026 2025 ────────────────────────────────────────────────────────────────────────────── Assets Current assets: Cash and cash $ 464.3 $ 365.4 equivalents Accounts 1,122.9 1,074.6 receivable, net Inventory 854.8 818.2 Other current 150.6 193.0 assets Total current 2,592.6 2,451.2 assets Property, plant and equipment, 778.9 766.8 net Other intangible 2,932.3 3,193.8 assets, net Goodwill, net 4,925.9 4,986.9 Other assets 400.3 396.0 Total assets $ 11,630.0 $ 11,794.7 Liabilities and stockholders' equity Current liabilities: Current portion $ 35.0 $ 30.8 of debt Accounts payable 735.4 741.7 Employee-related 174.0 162.7 liabilities Accrued interest 31.5 47.3 Other current 393.1 396.4 liabilities Total current 1,369.0 1,378.9 liabilities Debt, net of 3,648.8 3,915.5 current portion Deferred income 401.9 557.1 tax liabilities Other 374.4 378.2 liabilities Total 5,794.1 6,229.7 liabilities Stockholders’ equity: Common stock including 4,030.5 3,984.8 paid-in capital Treasury stock -75.7 -75.7 at cost Accumulated 1,957.6 1,672.8 earnings Accumulated other -76.5 -16.9 comprehensive loss Total stockholders’ 5,835.9 5,565.0 equity Total liabilities and $ 11,630.0 $ 11,794.7 stockholders' equity

1. Reflects charges incurred during the period related to restructuring initiatives to increase profitability and productivity. Costs included in this caption consist of employee severance, site-exit and contract termination costs, and non-cash impairment charges on long-lived assets associated with site exits.

2. Represents incremental expenses directly associated with the Company’s former cost transformation initiative, which concluded in 2025. These expenses are primarily related to the cost of external advisors.

3. Represents charges and legal costs, net of recoveries, incurred in connection with certain litigation and other contingencies that management evaluates separately from core operating performance.

4. Represents net foreign currency (gain) loss from financing activities, other stock-based compensation expense (benefit) and certain other items that management evaluates separately from core operating performance. The 2025 periods also include a purchase price adjustment related to the 2024 sale of our Clinical Services business and $6.1 million of severance and transition costs associated with the replacement of our Chief Executive Officer.

6. Represents the $785.0 million non-cash goodwill impairment charge recognized in the third quarter of 2025 related to the former Distribution reporting unit.

1. Reflects charges incurred during the period related to restructuring initiatives to increase profitability and productivity. Costs included in this caption consist of employee severance, site-exit and contract termination costs, and non-cash impairment charges on long-lived assets associated with site exits.

2. Represents incremental expenses directly associated with the Company’s former cost transformation initiative, which concluded in 2025. These expenses are primarily related to the cost of external advisors.

3. Represents charges and legal costs, net of recoveries, incurred in connection with certain litigation and other contingencies that management evaluates separately from core operating performance.

4. Represents other stock-based compensation expense (benefit) and certain other items that management evaluates separately from core operating performance. The 2025 periods also include a purchase price adjustment related to the 2024 sale of our Clinical Services business and $6.1 million of severance and transition costs associated with the replacement of our Chief Executive Officer.

5. Represents the $785.0 million non-cash goodwill impairment charge recognized in the third quarter of 2025 related to the former Distribution reporting unit.

(dollars in millions) September 30, 2026 ────────────────────────────────────────────────────────────────────────────── Total debt, gross $ 3,699.7 Less cash and cash equivalents -464.3 $ 3,235.4 Trailing twelve months Adjusted EBITDA $ 982.7 Trailing twelve months ongoing 47.5 stock-based compensation expense $ 1,030.2 Adjusted net leverage (non-GAAP) 3.1 x

Full text with the tables
                                                                                
  Exhibit 99.1                                                                  
                                                                                
                                                                                
                  Avantor® Reports Third Quarter 2026 Results                   
                                                                                
• Net sales of $1,698.3 million; increase of 4.6%; organic increase of 5.2%

• Diluted GAAP EPS of $0.30; adjusted EPS of $0.22

• Raised FY 2026 organic revenue growth, adjusted EPS and free cash flow
guidance
                                                                                
  RADNOR, Pa. – October 28, 2026                                                
                                                                                
–Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical
products and services to customers in the life sciences and advanced technology
industries, reports results that exceeded management’s expectations for revenue
and adjusted EPS for the third fiscal quarter of 2026.

Emmanuel Ligner, President and Chief Executive Officer, says: “We are delighted
to return to year-over-year growth in the third quarter. We are not done with
our Revival journey yet, but this achievement reflects the dedication of our
associates and the progress we are making to sharpen our strategic focus and
improve execution. Third quarter results exceeded our expectations across
revenue and adjusted EPS, and we generated robust free cash flow that allowed us
to further strengthen our balance sheet.

“VWR Distribution & Services delivered another quarter of improving revenue
performance, with organic growth accelerating to 5.8%, and Bioscience & Medtech
Products returned to organic growth as expected. We believe that improving
execution and stronger end markets provide a foundation for sustained revenue
growth, and we remain focused on execution to build on our positive momentum,”
Ligner concludes.
                                                                                
  Third Quarter 2026                                                            
                                                                                
For the three months ended September 30, 2026, net sales were $1,698.3 million,
which was up 4.6% compared to the third quarter of 2025. Foreign currency
translation had a negative impact of 0.6%, resulting in a 5.2% increase in net
sales on an organic basis.

Net income increased to $203.4 million from a net loss of $711.8 million in the
third quarter of 2025, and net income margin was 12.0%; adjusted net income was
$146.4 million compared to $151.1 million in the prior-year period. Adjusted
EBITDA was $256.9 million, with an adjusted EBITDA margin of 15.1%.

Operating income was $139.5 million, with an operating income margin of 8.2%;
adjusted operating income was $227.6 million, with an adjusted operating income
margin of 13.4%.

Diluted earnings per share on a GAAP basis was $0.30, and adjusted diluted
earnings per share was $0.22.
                                                                                
  Third Quarter 2026 – Segment Results                                          
                                                                                
VWR Distribution & Services

• Net sales were $1,233.8 million, a reported increase of 5.0%, as compared to
$1,175.0 million in the third quarter of 2025. Foreign currency translation had
a negative impact of 0.8%, resulting in a sales increase of 5.8% on an organic
basis.

• Adjusted Operating Income was $119.4 million as compared to $132.0 million in
the comparable prior period. Adjusted Operating Income margin was 9.7%. Adjusted
Operating Income margin declined versus the prior year due to unfavorable
product mix and higher SG&A expenses, partially offset by higher sales volume.

Bioscience & Medtech Products

• Net sales were $464.5 million, a reported increase of 3.5%, as compared to
$448.8 million in the third quarter of 2025. Foreign currency translation had a
negative impact of 0.1%, resulting in a 3.6% sales increase on an organic basis.

• Adjusted Operating Income was $123.4 million, as compared to $119.3 million in
the comparable prior period. Adjusted Operating Income margin was 26.6%.
Adjusted Operating Income margin was flat versus the prior year due to higher
sales volume and commercial excellence, partially offset by higher SG&A
expenses.

Adjusted Operating Income is Avantor's segment reporting profitability measure
under generally accepted accounting principles and is used by management to
measure and evaluate the performance of our Company’s business segments.
                                                                                
  Balance Sheet and Cash Flow                                                   
                                                                                
As of September 30, 2026, total debt, gross, was $3,699.7 million and cash and
cash equivalents were $464.3 million.

GAAP net leverage was 9.6x, and adjusted net leverage was 3.1x, as of September
30, 2026.

For the three months ended September 30, 2026, operating cash flow was $195.1
million, while free cash flow was $156.2 million.
                                                                                
  Updated 2026 Guidance                                                         
                                                                                
Avantor updates its fiscal 2026 financial guidance.
                                                                                
                                                      Updated Fiscal 2026       
                             Fiscal 2026 guidance     guidance                  
                             (as of July 29, 2026)    (as of October 28, 2026)  
 ────────────────────────────────────────────────────────────────────────────── 
  Organic revenue            -0.5% to +0.5%           +0.75% to +1.25%          
  growth(1)                                                                     
  Adjusted EBITDA            14.8% to 15.3%           14.8% to 15.3%            
  margin(1)                                                                     
  Adjusted EPS(1)            $0.80 to $0.83           $0.81 to $0.83            
  Free cash flow(1)(2)       $500M to $550M           $525M to $550M            
                                                                                
(1) Non-GAAP measure (definitions and/or reconciliations below). We are unable
to provide a reconciliation of the non-GAAP measures provided in our full-year
2026 guidance without unreasonable effort because of the difficulty in
forecasting and quantifying certain amounts and adjustment items with a
reasonable degree of certainty including net income, restructuring charges,
foreign currency exchange gains and losses and income tax expense. These amounts
are dependent upon future events and may be outside of our control. We note that
these items could have a significant impact on our full-year results determined
in accordance with GAAP.

(2) Excludes cash restructuring costs.
                                                                                
  Fiscal 2026 Assumptions                                                       
                                                                                
• Reported revenue growth range is +1.5% to +2.0%, reflecting +0.75% foreign
exchange tailwind

• Blended EUR/USD exchange rate of 1.15

• Net interest expense is expected to decline modestly when compared to Fiscal
2025

• Adjusted effective tax rate between 22.0% and 22.5%

• Fully diluted share count of 679M shares
                                                                                
  Conference Call                                                               
                                                                                
We will host a conference call to discuss our results today, October 28, 2026 at
8:00 a.m. Eastern Time. The live webcast and presentation, as well as a replay,
will be available on the investor section of Avantor's website .
                                                                                
  About Avantor                                                                 
                                                                                
Avantor ® is a leading life science tools company and global provider of
mission-critical products and services to the life sciences and advanced
technology industries. We work side-by-side with customers at every step of the
scientific journey to enable breakthroughs in medicine, healthcare, and
technology. Our portfolio is used in virtually every stage of the most important
research, development and production activities at more than 300,000 customer
locations in 180 countries. For more information, visit
corporate.avantorsciences.com and find us on LinkedIn , X (Twitter) and Facebook
.
                                                                                
   Use of Non-GAAP Financial Measures                                           
                                                                                
To evaluate our performance, we monitor a number of key indicators. As
appropriate, we supplement our results of operations determined in accordance
with U.S. generally accepted accounting principles (“GAAP”) with certain non-
GAAP financial measures that we believe are useful to investors, creditors and
others in assessing our performance. These measures should not be considered in
isolation or as a substitute for reported GAAP results because they may include
or exclude certain items as compared to similar GAAP-based measures, and such
measures may not be comparable to similarly titled measures reported by other
companies. Rather, these measures should be considered as an additional way of
viewing aspects of our operations that provide a more complete understanding of
our business. We strongly encourage investors to review our consolidated
financial statements included in reports filed with the SEC in their entirety
and not rely solely on any one single financial measure or communication.

The non-GAAP financial measures used in this press release are sales growth
(decline) on an organic basis, Adjusted Operating Income, Adjusted Operating
Income margin, Adjusted EBITDA, Adjusted EBITDA margin, adjusted net income,
adjusted EPS, adjusted net leverage, free cash flow and free cash flow
conversion.

• Organic net sales growth (decline) eliminates from our reported net sales
change the impacts of revenues from acquisitions and divestitures that occurred
in the last year (as applicable) and changes in foreign currency exchange rates.
We believe that this measurement is useful to investors as a way to measure and
evaluate our underlying commercial operating performance consistently across our
segments and the periods presented. This measure is used by our management for
the same reason.

• Adjusted Operating Income is our operating income or loss adjusted for the
following items: (i) amortization of acquired intangible assets, (ii) charges
associated with the impairment of certain assets, (iii) gain or loss on sale of
business, and (iv) certain other adjustments. Adjusted Operating Income margin
is Adjusted Operating Income divided by net sales as determined under GAAP. We
believe that these measures are useful to investors as ways to analyze the
underlying trends in our business consistently across the periods presented.
These measures are used by our management for the same reason. Additionally,
Adjusted Operating Income is our segment reporting profitability measure under
GAAP.

• Adjusted EBITDA is our net income or loss adjusted for the following items:
(i) interest expense, (ii) income tax expense, (iii) amortization of acquired
intangible assets, (iv) depreciation expense, (v) losses on extinguishment of
debt, (vi) charges associated with the impairment of certain assets, (vii) gain
or loss on sale of business, and (viii) certain other adjustments. Adjusted
EBITDA margin is Adjusted EBITDA divided by net sales as determined under GAAP.
We believe that these measures are useful to investors as ways to analyze the
underlying trends in our business consistently across the periods presented.
These measures are used by our management for the same reason.

• Adjusted net income is our net income or loss first adjusted for the following
items: (i) amortization of acquired intangible assets, (ii) losses on
extinguishment of debt, (iii) charges associated with the impairment of certain
assets, (iv) gain or loss on sale of business, and (v) certain other
adjustments. From this amount, we then add or subtract an assumed incremental
income tax impact on the above-noted pre-tax adjustments, using estimated tax
rates, to arrive at Adjusted Net Income. We believe that this measure is useful
to investors as a way to analyze the business consistently across the periods
presented. This measure is used by our management for the same reason.

• Adjusted EPS is our adjusted net income divided by our diluted GAAP weighted
average share count adjusted for anti-dilutive instruments. We believe that this
measure is useful to investors as an additional way to analyze the underlying
trends in our business consistently across the periods presented. This measure
is used by our management for the same reason.

• Adjusted net leverage is equal to our gross debt, reduced by our cash and cash
equivalents, divided by our trailing 12-month Adjusted EBITDA (excluding stock-
based compensation expense and including the expected run-rate effect of cost
synergies and the incremental results of completed acquisitions and divestitures
as if those acquisitions and divestitures had occurred on the first day of the
trailing 12-month period). We believe that this measure is useful to investors
as a way to evaluate and measure the Company’s capital allocation strategies and
the underlying trends in the business. This measure is used by our management
for the same reason.

• Free cash flow is equal to our cash flows from operating activities, less
capital expenditures, plus direct transaction costs and income taxes paid
related to acquisitions and divestitures (as applicable) in the period. Free
cash flow conversion is free cash flow divided by adjusted net income. We
believe that these measures are useful to investors as they provide a view on
the Company’s ability to generate cash for use in financing or investing
activities. These measures are used by our management for the same reason.

Reconciliations of these non-GAAP financial measures to the most directly
comparable GAAP financial measures are included in the tables accompanying this
release.
                                                                                
  Forward-Looking and Cautionary Statements                                     
                                                                                
This press release contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934, and are subject to the safe harbor created thereby under
the Private Securities Litigation Reform Act of 1995. All statements other than
statements of historical fact included in this press release are forward-looking
statements. Forward-looking statements discuss our current expectations and
projections relating to our financial condition, results of operations, plans,
objectives, future performance and business. These statements may be preceded
by, followed by or include the words “aim,” “anticipate,” “assumption,”
“believe,” “continue,” “estimate,” “expect,” “forecast,” “goal,” “guidance,”
“intend,” “likely,” “long-term,” “near-term,” “objective,” “opportunity,”
“outlook,” “plan,” “potential,” “project,” “projection,” “prospects,” “seek,”
“target,” “trend,” “can,” “could,” “may,” “should,” “would,” “will,” the
negatives thereof and other words and terms of similar meaning.

Forward-looking statements are inherently subject to risks, uncertainties and
assumptions; they are not guarantees of performance. You should not place undue
reliance on these statements. We have based these forward-looking statements on
our current expectations and projections about future events. Although we
believe that our assumptions made in connection with the forward-looking
statements are reasonable, we cannot assure you that the assumptions and
expectations will prove to be correct. Factors that could contribute to these
risks, uncertainties and assumptions include, but are not limited to, the
factors described in “Risk Factors” in our most recent Annual Report on Form
10-K, and subsequent quarterly reports on Form 10-Q, as such risk factors may be
updated from time to time in our periodic filings with the SEC.

All forward-looking statements attributable to us or persons acting on our
behalf are expressly qualified in their entirety by the foregoing cautionary
statements. In addition, all forward-looking statements speak only as of the
date of this press release. We undertake no obligations to update or revise
publicly any forward-looking statements, whether as a result of new information,
future events or otherwise other than as required under the federal securities
laws.
                                                                                
  Avantor, Inc. and subsidiaries                                                
                                                                                
Unaudited condensed consolidated statements of operations
                                                                                
  (in                                                                           
  mi…                                                                           
  ex…    Thr…                                     Nine                          
  per    mon…                                     mon…                          
  sh…    end…                                     end…                          
  da…    Sep…                                     Sep…                          
  20…    30,           2025               2026    30,           2025            
 ────────────────────────────────────────────────────────────────────────────── 
  Net    $     1,6…            $  1,6…            $     4,9…            $  4,…  
  sa…                                                                           
  Co…                                                                           
  of           1,1…               1,0…                  3,3…               3,…  
  sa…                                                                           
  Gr…          534…               526…                  1,5…               1,…  
  pr…                                                                           
  Se…                                                                           
  ge…                                                                           
  and          395…               390…                  1,2…               1,…  
  ad…                                                                           
  ex…                                                                           
  Im…             —               785…                     —               78…  
  ch…                                                                           
  Op…                                                                           
  in…          139…               -64…                  360…               -3…  
  (l…                                                                           
  In…                                                                           
  ex…          -39…               -44…                  -12…               -1…  
  net                                                                           
  Lo…                                                                           
  on                                                                            
  ex…          -0.8               -0.2                  -2.0               -0…  
  of                                                                            
  de…                                                                           
  Ot…                                                                           
  (e…          -0.8                3.7                  -1.9               -1…  
  in…                                                                           
  net                                                                           
  In…                                                                           
  (l…                                                                           
  be…          98.0               -68…                  234…               -5…  
  in…                                                                           
  ta…                                                                           
  In…                                                                           
  tax          105…               -22…                  50.1               -6…  
  be…                                                                           
  (e…                                                                           
  Net                                                                           
  in…    $     203…            $  -71…            $     284…            $  -5…  
  (l…                                                                           
  Ea…                                                                           
  (l…                                                                           
  per                                                                           
  sh…                                                                           
  Ba…    $     0.30            $  -1.…            $     0.42            $  -0…  
  Di…    $     0.30            $  -1.…            $     0.42            $  -0…  
  We…                                                                           
  av…                                                                           
  sh…                                                                           
  ou…                                                                           
  Ba…          677…               681…                  676…               68…  
  Di…          680…               681…                  677…               68…  
                                                                                
                                                                                
  Avantor, Inc. and subsidiaries                                                
                                                                                
Unaudited condensed consolidated balance sheets
                                                                                
                                          September 30,           December 31,  
                    (in millions)                  2026                   2025  
 ────────────────────────────────────────────────────────────────────────────── 
  Assets                                                                        
  Current assets:                                                               
  Cash and cash                    $              464.3    $             365.4  
  equivalents                                                                   
  Accounts                                      1,122.9                1,074.6  
  receivable, net                                                               
  Inventory                                       854.8                  818.2  
  Other current                                   150.6                  193.0  
  assets                                                                        
  Total current                                 2,592.6                2,451.2  
  assets                                                                        
  Property, plant                                                               
  and equipment,                                  778.9                  766.8  
  net                                                                           
  Other intangible                              2,932.3                3,193.8  
  assets, net                                                                   
  Goodwill, net                                 4,925.9                4,986.9  
  Other assets                                    400.3                  396.0  
  Total assets                     $           11,630.0    $          11,794.7  
  Liabilities and                                                               
  stockholders'                                                                 
  equity                                                                        
  Current                                                                       
  liabilities:                                                                  
  Current portion                  $               35.0    $              30.8  
  of debt                                                                       
  Accounts payable                                735.4                  741.7  
  Employee-related                                174.0                  162.7  
  liabilities                                                                   
  Accrued interest                                 31.5                   47.3  
  Other current                                   393.1                  396.4  
  liabilities                                                                   
  Total current                                 1,369.0                1,378.9  
  liabilities                                                                   
  Debt, net of                                  3,648.8                3,915.5  
  current portion                                                               
  Deferred income                                 401.9                  557.1  
  tax liabilities                                                               
  Other                                           374.4                  378.2  
  liabilities                                                                   
  Total                                         5,794.1                6,229.7  
  liabilities                                                                   
  Stockholders’                                                                 
  equity:                                                                       
  Common stock                                                                  
  including                                     4,030.5                3,984.8  
  paid-in capital                                                               
  Treasury stock                                  -75.7                  -75.7  
  at cost                                                                       
  Accumulated                                   1,957.6                1,672.8  
  earnings                                                                      
  Accumulated                                                                   
  other                                           -76.5                  -16.9  
  comprehensive                                                                 
  loss                                                                          
  Total                                                                         
  stockholders’                                 5,835.9                5,565.0  
  equity                                                                        
  Total                                                                         
  liabilities and                  $           11,630.0    $          11,794.7  
  stockholders'                                                                 
  equity                                                                        
                                                                                
                                                                                
  Avantor, Inc. and subsidiaries                                                
                                                                                
Unaudited condensed consolidated statements of cash flows
                                                                                
  (in                                                                           
  mi…                                                                           
  20…                                                                           
  Ca…    Thr…                                     Nine                          
  fl…    mon…                                     mon…                          
  fr…    end…                                     end…                          
  op…    Sep…                                     Sep…                          
  ac…    30,           2025               2026    30,           2025            
 ────────────────────────────────────────────────────────────────────────────── 
  Net                                                                           
  in…    $     203…            $  -71…            $     284…            $  -5…  
  (l…                                                                           
  Re…                                                                           
  ad…                                                                           
  De…                                                                           
  and          105…               104…                  315…               30…  
  am…                                                                           
  Im…             —               785…                     —               78…  
  ch…                                                                           
  St…                                                                           
  co…          12.5                7.2                  36.5               35…  
  ex…                                                                           
  No…                                                                           
  re…             —                  —                   5.0                 —  
  ch…                                                                           
  Pr…                                                                           
  for                                                                           
  ac…          19.0               16.5                  46.2               43…  
  re…                                                                           
  and                                                                           
  in…                                                                           
  De…                                                                           
  in…          -14…               -11…                  -14…               -4…  
  tax                                                                           
  be…                                                                           
  Am…                                                                           
  of                                                                            
  de…           1.8                2.1                   5.3               6.6  
  fi…                                                                           
  co…                                                                           
  Lo…                                                                           
  on                                                                            
  ex…           0.8                0.2                   2.0               0.2  
  of                                                                            
  de…                                                                           
  Fo…                                                                           
  cu…                                                                           
  re…           0.4               -3.1                  -0.5               0.7  
  lo…                                                                           
  (g…                                                                           
  Pe…                                                                           
  te…             —                  —                     —               18…  
  ch…                                                                           
  Ch…                                                                           
  in                                                                            
  as…                                                                           
  and                                                                           
  li…                                                                           
  Ac…          12.4               66.2                  -68…               10…  
  re…                                                                           
  In…          -44…               -33…                  -90…               -6…  
  Ac…          -10…               -23…                   7.5               -4…  
  pa…                                                                           
  Ac…          -14…               -14…                  -15…               -1…  
  in…                                                                           
  Ot…                                                                           
  as…          54.6               25.5                  42.9               -2…  
  and                                                                           
  li…                                                                           
  Ot…           1.1               -1.3                   2.4               1.0  
  Net                                                                           
  ca…                                                                           
  pr…          195…               207…                  432…               47…  
  by                                                                            
  op…                                                                           
  ac…                                                                           
  Ca…                                                                           
  fl…                                                                           
  fr…                                                                           
  in…                                                                           
  ac…                                                                           
  Ca…          -38…               -35…                  -11…               -9…  
  ex…                                                                           
  Ot…           0.4                2.4                   1.5               2.5  
  Net                                                                           
  ca…                                                                           
  us…          -38…               -33…                  -10…               -9…  
  in                                                                            
  in…                                                                           
  ac…                                                                           
  Ca…                                                                           
  fl…                                                                           
  fr…                                                                           
  fi…                                                                           
  ac…                                                                           
  De…          54.0               67.7                  54.0               67…  
  bo…                                                                           
  De…          -63…               -43…                  -28…               -4…  
  re…                                                                           
  Pr…                                                                           
  re…                                                                           
  fr…                                                                           
  ex…          12.7                2.3                  14.6               4.9  
  of                                                                            
  st…                                                                           
  op…                                                                           
  Sh…                                                                           
  re…                                                                           
  to                                                                            
  sa…                                                                           
  em…                                                                           
  tax          -1.1               -0.4                  -5.0               -5…  
  ob…                                                                           
  for                                                                           
  ve…                                                                           
  st…                                                                           
  aw…                                                                           
  Ot…          -0.7                  —                  -0.8                 —  
  Net                                                                           
  ca…                                                                           
  pr…                                                                           
  by            1.8               -36…                  -21…               -4…  
  (u…                                                                           
  in)                                                                           
  fi…                                                                           
  ac…                                                                           
  Ef…                                                                           
  of                                                                            
  cu…                                                                           
  ra…                                                                           
  ch…          -0.9               -2.0                  -6.8               19…  
  on                                                                            
  ca…                                                                           
  and                                                                           
  ca…                                                                           
  eq…                                                                           
  Net                                                                           
  ch…                                                                           
  in                                                                            
  ca…                                                                           
  ca…          157…               -19…                  98.9               -1…  
  eq…                                                                           
  and                                                                           
  re…                                                                           
  ca…                                                                           
  Ca…                                                                           
  ca…                                                                           
  eq…                                                                           
  and                                                                           
  re…          309…               452…                  368…               26…  
  ca…                                                                           
  be…                                                                           
  of                                                                            
  pe…                                                                           
  Ca…                                                                           
  ca…                                                                           
  eq…                                                                           
  and                                                                           
  re…    $     467…            $  254…            $     467…            $  25…  
  ca…                                                                           
  end                                                                           
  of                                                                            
  pe…                                                                           
                                                                                
                                                                                
  Avantor, Inc. and subsidiaries                                                
                                                                                
                                                                                
  Reconciliations of non-GAAP measures                                          
                                                                                
                                                                                
  Adjusted EBITDA and Adjusted EBITDA Margin                                    
                                                                                
                                                                                
                                      …                    …                    
 ────────────────────────────────────────────────────────────────────────────── 
                                      $                    $                    
                                 …           …        …           …        …    
                                 …           …        …           …        …    
                                 —           …        —           …        —    
                                 …           …        …           …        …    
                                 …           —        —           …        …    
                                 …           …        …           …        …    
                                 …           …        …           …        …    
                                 …           —        —           …        …    
                                 …           —        —           …        …    
                                 …           …        …           …        …    
                                 …           …        …           …        …    
                                 …           …        …           …        …    
                                 …           …        …           …        …    
                                 …           …        …           …        …    
                                 …           …        …           …        …    
                                                                                
━━━━━━━━━

1. Reflects charges incurred during the period related to restructuring
initiatives to increase profitability and productivity. Costs included in this
caption consist of employee severance, site-exit and contract termination costs,
and non-cash impairment charges on long-lived assets associated with site exits.

2. Represents incremental expenses directly associated with the Company’s former
cost transformation initiative, which concluded in 2025. These expenses are
primarily related to the cost of external advisors.

3. Represents charges and legal costs, net of recoveries, incurred in connection
with certain litigation and other contingencies that management evaluates
separately from core operating performance.

4. Represents net foreign currency (gain) loss from financing activities, other
stock-based compensation expense (benefit) and certain other items that
management evaluates separately from core operating performance. The 2025
periods also include a purchase price adjustment related to the 2024 sale of our
Clinical Services business and $6.1 million of severance and transition costs
associated with the replacement of our Chief Executive Officer.

5. Represents pension termination charges related to termination of our U.S.
Pension Plan.

6. Represents the $785.0 million non-cash goodwill impairment charge recognized
in the third quarter of 2025 related to the former Distribution reporting unit.
                                                                                
  Avantor, Inc. and subsidiaries                                                
                                                                                
                                                                                
  Reconciliations of non-GAAP measures (continued)                              
                                                                                
Adjusted Operating Income and Adjusted Operating Income Margin
                                                                                
                                      …                    …                    
 ────────────────────────────────────────────────────────────────────────────── 
                                      $                    $                    
                                 …           …        …           …        …    
                                 …           …        …           …        …    
                                 …           …        …           …        …    
                                 —           …        —           …        —    
                                 …           …        —           …        …    
                                 …           …        …           …        …    
                                 …           …        …           …        …    
                                 …           …        …           …        …    
                                 …           —        —           …        …    
                                 …           …        …           …        …    
                                 …           …        —           …        …    
                                 …           —        —           …        …    
                                 …           …        …           …        …    
                                                                                
━━━━━━━━━

1. Reflects charges incurred during the period related to restructuring
initiatives to increase profitability and productivity. Costs included in this
caption consist of employee severance, site-exit and contract termination costs,
and non-cash impairment charges on long-lived assets associated with site exits.

2. Represents incremental expenses directly associated with the Company’s former
cost transformation initiative, which concluded in 2025. These expenses are
primarily related to the cost of external advisors.

3. Represents charges and legal costs, net of recoveries, incurred in connection
with certain litigation and other contingencies that management evaluates
separately from core operating performance.

4. Represents other stock-based compensation expense (benefit) and certain other
items that management evaluates separately from core operating performance. The
2025 periods also include a purchase price adjustment related to the 2024 sale
of our Clinical Services business and $6.1 million of severance and transition
costs associated with the replacement of our Chief Executive Officer.

5. Represents the $785.0 million non-cash goodwill impairment charge recognized
in the third quarter of 2025 related to the former Distribution reporting unit.
                                                                                
  Avantor, Inc. and subsidiaries                                                
                                                                                
                                                                                
  Reconciliations of non-GAAP measures (continued)                              
                                                                                
Adjusted earnings per share
                                                                                
         Thr…                                     Nine                          
  (s…    mon…                                     mon…                          
  in     end…                                     end…                          
  mi…    Sep…                                     Sep…                          
  20…    30,           2025               2026    30,           2025            
 ────────────────────────────────────────────────────────────────────────────── 
  Di…                                                                           
  ea…                                                                           
  (l…    $     0.30            $  -1.…            $     0.42            $  -0…  
  per                                                                           
  sh…                                                                           
  (G…                                                                           
  Am…          0.11               0.11                  0.34               0.…  
  Lo…                                                                           
  on                                                                            
  ex…             —                  —                     —                 —  
  of                                                                            
  de…                                                                           
  Re…                                                                           
  se…                                                                           
  and          0.01                  —                  0.07               0.…  
  re…                                                                           
  im…                                                                           
  ch…                                                                           
  Tr…             —               0.02                     —               0.…  
  ex…                                                                           
  Re…                                                                           
  for                                                                           
  ce…             —                  —                  0.01               0.…  
  le…                                                                           
  ma…                                                                           
  net                                                                           
  Ot…          0.01               0.01                     —               0.…  
  Pe…                                                                           
  te…             —                  —                     —               0.…  
  ch…                                                                           
  Im…             —               1.15                     —               1.…  
  ch…                                                                           
  In…                                                                           
  tax                                                                           
  be…                                                                           
  ap…          -0.…               -0.…                  -0.…               -0…  
  to                                                                            
  pr…                                                                           
  ad…                                                                           
  Ad…                                                                           
  EPS    $     0.22            $  0.22            $     0.60            $  0.…  
  (n…                                                                           
  We…                                                                           
  av…                                                                           
  di…                                                                           
  sh…                                                                           
  ou…                                                                           
  Sh…                                                                           
  co…                                                                           
  for          680…               681…                  677…               68…  
  Ad…                                                                           
  EPS                                                                           
  (n…                                                                           
                                                                                
Free cash flow
                                                                                
         Thr…                                     Nine                          
         mon…                                     mon…                          
  (in    end…                                     end…                          
  mi…    Sep…                                     Sep…                          
  20…    30,           2025               2026    30,           2025            
 ────────────────────────────────────────────────────────────────────────────── 
  Net                                                                           
  ca…                                                                           
  pr…    $     195…            $  207…            $     432…            $  47…  
  by                                                                            
  op…                                                                           
  ac…                                                                           
  Ca…          -38…               -35…                  -11…               -9…  
  ex…                                                                           
  Di…                                                                           
  tr…                                                                           
  ex…             —                  —                   2.2               1.4  
  and                                                                           
  ta…                                                                           
  pa…                                                                           
  Fr…                                                                           
  ca…    $     156…            $  171…            $     324…            $  37…  
  fl…                                                                           
  (n…                                                                           
                                                                                
GAAP net leverage
                                                                           
  (dollars in millions)                September 30, 2026                  
 ───────────────────────────────────────────────────────────────────────── 
  Total debt, gross                    $                   3,699.7         
  Less cash and cash equivalents                            -464.3         
                                       $                   3,235.4         
  Trailing twelve months net income    $                     337.2         
  GAAP net leverage                                                 9.6 x  
                                                                           
                                                                                
  Adjusted net leverage                                                         
                                                                                
                                                                                
  (dollars in millions)                     September 30, 2026                  
 ────────────────────────────────────────────────────────────────────────────── 
  Total debt, gross                         $                   3,699.7         
  Less cash and cash equivalents                                 -464.3         
                                            $                   3,235.4         
  Trailing twelve months Adjusted EBITDA    $                     982.7         
  Trailing twelve months ongoing                                   47.5         
  stock-based compensation expense                                              
                                            $                   1,030.2         
  Adjusted net leverage (non-GAAP)                                       3.1 x  
                                                                                
                                                                                
  Avantor, Inc. and subsidiaries                                                
                                                                                
                                                                                
  Reconciliations of non-GAAP measures (continued)                              
                                                                                
                                                                                
  Net sales by segment                                                          
                                                                                
                                                                                
                                         Re…                                    
                                         of                                     
                                         net                                    
                                         sa…                                    
                                         gr…                                    
  (in                                    (d…                                    
  mi…                                    to                                     
  Net                                    or…          Or…                       
  sa…                  Fo…               net          net                       
  gr…                  cu…               sa…          sa…                       
  (d…    Sep…          im…               gr…          gr…                       
  20…    30,           20…               (d…          (d…                       
 ────────────────────────────────────────────────────────────────────────────── 
         $                    $          $                   $          $       
  Th…                                                                           
  mo…                                                                           
  en…                                                                           
  Bi…                                                                           
  &      $     464…           $  448…    $    15.7           $  -0.6    $  16…  
  Me…                                                                           
  Pr…                                                                           
  VWR                                                                           
  Di…          1,2…              1,1…         58.8              -9.0       67…  
  &                                                                             
  Se…                                                                           
  To…    $     1,6…           $  1,6…    $    74.5           $  -9.6    $  84…  
  Ni…                                                                           
  mo…                                                                           
  en…                                                                           
  Bi…                                                                           
  &      $     1,3…           $  1,3…    $    -3.4           $  15.7    $  -1…  
  Me…                                                                           
  Pr…                                                                           
  VWR                                                                           
  Di…          3,6…              3,5…         86.8              54.7       32…  
  &                                                                             
  Se…                                                                           
  To…    $     4,9…           $  4,8…    $    83.4           $  70.4    $  13…  
                                                                                
                                                                                
  (…                                                                            
  in                                 Re…                                        
  m…                                 of                                         
  %                                  net                                        
  b…                                 sa…                                        
  on                                 gr…                                        
  n…                                 (d…                                        
  s…                                 to                                         
  N…                                 or…                       O…               
  s…                Fo…              net                       n…               
  g…                cu…              sa…                       s…               
  (…    Se…         im…              gr…                       g…               
  2…    30,         20…              (d…                       (…               
 ────────────────────────────────────────────────────────────────────────────── 
        $                  $         %              %                %          
  T…                                                                            
  m…                                                                            
  e…                                                                            
  B…                                                                            
  &     $    46…           $  44…         3.5  %       -0…  %           3.6  %  
  M…                                                                            
  P…                                                                            
  V…                                                                            
  D…         1,…              1,…         5.0  %       -0…  %           5.8  %  
  &                                                                             
  S…                                                                            
  T…    $    1,…           $  1,…         4.6  %       -0…  %           5.2  %  
  N…                                                                            
  m…                                                                            
  e…                                                                            
  B…                                                                            
  &     $    1,…           $  1,…         -0…  %       1.1  %           -1…  %  
  M…                                                                            
  P…                                                                            
  V…                                                                            
  D…         3,…              3,…         2.5  %       1.6  %           0.9  %  
  &                                                                             
  S…                                                                            
  T…    $    4,…           $  4,…         1.7  %       1.4  %           0.3  %  
                                                                                
                                                                                
  Adjusted Operating Income by segment                                          
                                                                                
                                                                                
      …                                                                         
      …                                                                         
      …                                                                         
      …                                                                         
      …                …                  …                  …                  
 ────────────────────────────────────────────────────────────────────────────── 
      $       %                                                                 
      $  …       …  %         …      …           …      …           …      …    
         …       …  %         …      …           …      …           …      …    
         …       —  %         …      —           …      —           …      —    
      $  …       …  %         …      …           …      …           …      …    
                                                                                
                                                                                
  Investor Relations Contact                                                    
                                                                                
Chris Fidyk

Vice President, Investor Relations

Avantor

[email protected]
                                                                                
  Global Media Contact                                                          
                                                                                
Valerie Collado

Director, External Communications and Community Impact

Avantor

484-885-9338

[email protected]

Source: Avantor and Financial News

Sources

The 8-K item 2.02 filings (SEC EDGAR) and their EX-99 exhibits: the results release and, when filed, prepared remarks or the call transcript.

Also

Said vs did: the targets in these releases against what was then reported. Filings: every filing.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/AVTR/export.csv") into a cell.

Next:Presentations
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.